
Nutriband Advances Fentanyl Abuse-Deterrent Patch with FDA Meeting and Leadership Transition
Nutriband Inc. secures a critical FDA meeting for its AVERSA™ Fentanyl abuse-deterrent patch while navigating CEO transition during a pivotal development phase targeting the opioid crisis.
Read full story


























